Evidence map›Paper›PMID 41496837›Full record

ArticleRSC advances2026

Effect of monothiophosphinic acid and phosphine sulfide impurities on the solvent extraction behavior of bis(2,4,4-trimethylpentyl)dithiophosphinic acid from sulfate and methanesulfonate media.

Tim Balcaen, Koen Binnemans, Stijn Raiguel

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tim BalcaenKU Leuven, Department of Chemistry Celestijnenlaan 200F, P.O. Box 2404 B-3001 Leuven Belgium stijn.raiguel@kuleuven.be.ORCID https://orcid.org/0000-0001-5108-525X
Koen BinnemansKU Leuven, Department of Chemistry Celestijnenlaan 200F, P.O. Box 2404 B-3001 Leuven Belgium stijn.raiguel@kuleuven.be.ORCID https://orcid.org/0000-0003-4768-3606
Stijn RaiguelKU Leuven, Department of Chemistry Celestijnenlaan 200F, P.O. Box 2404 B-3001 Leuven Belgium stijn.raiguel@kuleuven.be.ORCID https://orcid.org/0000-0001-5185-9673

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A crude, synthesized mixture of bis(2,4,4-trimethylpentyl)dithiophosphinic acid (DTPhos), was evaluated as a functional alternative to the discontinued Cyanex® 301 extractant. This study enabled the assessment of the influence of common impurities, such as bis(2,4,4-trimethylpentyl)monothiophosphinic acid (MTPhos) and phosphine sulfides, on metal extraction performance from methanesulfonate (MSA) and sulfate media. Both extractants exhibited nearly quantitative extraction of Ni(ii), Co(ii), and Zn(ii) under non-saponified conditions. In contrast to Cyanex 301, synthesized DTPhos-based mixtures did not give rise to third-phase formation at elevated pH values in methanesulfonate media. Additionally, Mn(ii) was extracted at lower pH values with the DTPhos mixtures than with Cyanex 301. Regression analysis of distribution ratios confirmed comparable cobalt(ii) extraction efficiencies and revealed a moderate reduction in separation from nickel(ii) for the least-enriched DTPhos formulation. Overall, the effect of the DTPhos impurity on the extraction properties was limited under the investigated conditions. Furthermore, variations in extraction mechanisms were suggested by pH-dependent behavior, particularly in sulfate-based systems. These findings support the use of synthesized DTPhos as a viable alternative to Cyanex 301, offering practical benefits such as stability against third-phase formation and flexibility in extractant composition.

Identifiers

PMID41496837
PMCPMC12766893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.